-
Forward Look
Breast Density MattersBreast cancer risk factor may be overlooked.
by Kendall K. Morgan
-
Forward Look
More Options for Adolescents in Clinical TrialsNew recommendations support inclusion of teens in adult studies.
by Susan Kreimer
-
Forward Look
Choosing a Cancer CenterNCI-designated cancer centers play an important role in patient care.
by Kristine Meldrum Denholm
-
Forward Look
The Cost of PrescriptionsFinancial factors can influence cancer patients' use of medications
by Kate Yandell
-
Forward Look
Tackling Drug ResistanceResearchers are studing new ways to keep treatments working longer.
by Stephen Ornes
-
A New Look for Clinical TrialsMore focused efforts aim to increase the number and type of participants in research studies. One goal is for study participants to be more like the patients who will take the drug if it is approved.
by Sue Rochman
-
The Kindest CutBefore undergoing surgery, cancer patients should look for experienced surgeons, get second opinions and ask about the risks and benefits.
by Stephen Ornes
-
Going Off-LabelPhysicians are legally permitted to prescribe drugs approved for one purpose to be used for another, a practice called off-label prescribing. The rise of targeted therapies and immunotherapies is creating new challenges for navigating off-label options.
by Kate Yandell
-
A Focus on Pediatric Cancer ScreeningThe AACR shares research papers that summarize recommendations for monitoring children and adolescents with cancer predisposition syndromes.
by Garrett M. Brodeur
-
Revised Prostate Cancer Screening Guidelines Proposed
The U.S. Preventive Services Task Force suggests an individualized approach to prostate cancer screening.
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
